Posted 26 January, 2024

ArriVent Biopharma, Inc. IPO completed

IPO completed detected for ticker Nasdaq:AVBP in a 424B4 filed on 26 January, 2024.

  This is an initial public offering of shares of common stock of ArriVent BioPharma, Inc.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of ArriVent Biopharma, Inc.
Health Care/Life Sciences • Biotechnology
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Market Cap
View Company Details